Claudia Heß by EastCyte Biosciences GmbH cooperates with the American company NORTIS BIO aiming to open up the European market. The Organ-on-Chip is a microfluidic platform that is built for growing organ models. Thus, the architecture and function of in-vivo cells and tissues can be reconstructed. As a result, medications and their effects can be tested before they are used on real organs.

EastCyte Biosciences
Claudia Heß and Thomas Neumann (Source: Michael Deutsch)